This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Nov 20;33(33):3851-3.

doi: 10.1200/JCO.2015.63.1143. Epub 2015 Aug 17.

Advances in the Treatment of Secondary CNS Lymphoma

Norbert Schmitz¹, Huei Shan Wu²

Affiliations

PMID: 26282665
DOI: 10.1200/JCO.2015.63.1143

Editorial

Advances in the Treatment of Secondary CNS Lymphoma

Norbert Schmitz et al. J Clin Oncol. 2015.

. 2015 Nov 20;33(33):3851-3.

doi: 10.1200/JCO.2015.63.1143. Epub 2015 Aug 17.

Authors

Norbert Schmitz¹, Huei Shan Wu²

Affiliations

¹ Asklepios Hospital St Georg, Hamburg, Germany n.schmitz@asklepios.com.
² Asklepios Hospital St Georg, Hamburg, Germany.

PMID: 26282665
DOI: 10.1200/JCO.2015.63.1143

No abstract available

PubMed Disclaimer

Comment on

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
Ferreri AJ, Donadoni G, Cabras MG, Patti C, Mian M, Zambello R, Tarella C, Di Nicola M, D'Arco AM, Doa G, Bruno-Ventre M, Assanelli A, Foppoli M, Citterio G, Fanni A, Mulè A, Caligaris-Cappio F, Ciceri F. Ferreri AJ, et al. J Clin Oncol. 2015 Nov 20;33(33):3903-10. doi: 10.1200/JCO.2015.61.1236. Epub 2015 Aug 17. J Clin Oncol. 2015. PMID: 26282634 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.